Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89122933 | 8912293 | 3 | F | 20120717 | 20160722 | 20121115 | 20160801 | EXP | GB-PFIZER INC-2012277057 | PFIZER | 52.00 | YR | F | Y | 66.70000 | KG | 20160801 | OT | GB | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89122933 | 8912293 | 1 | PS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 690 MG, 1 IN 14 DAYS | U | 8107 | 690 | MG | |||||||
| 89122933 | 8912293 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous drip | 4150 MG, 1 IN 14 DAYS | Y | UNK | 0 | 4150 | MG | ||||||
| 89122933 | 8912293 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 150 MG, 1 IN 14 DAYS | Y | UNK | 78813 | 150 | MG | ||||||
| 89122933 | 8912293 | 4 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous drip | 330 MG, 1 IN 14 DAYS | Y | 931932 | 0 | 330 | MG | ||||||
| 89122933 | 8912293 | 5 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Intravenous (not otherwise specified) | UNK, 1 IN 14 DAYS | Y | EP46861 | 0 | ||||||||
| 89122933 | 8912293 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | |||||||||||
| 89122933 | 8912293 | 7 | C | VITAMIN B | VITAMIN B | 1 | Oral | 0 | |||||||||||
| 89122933 | 8912293 | 8 | C | FISH OIL | FISH OIL | 1 | Oral | UNK | 0 | ||||||||||
| 89122933 | 8912293 | 9 | C | VITAMIN A | VITAMIN A | 1 | Oral | 5000 IU, UNK | 0 | 5000 | IU | ||||||||
| 89122933 | 8912293 | 10 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 89122933 | 8912293 | 11 | C | TROPISETRON | TROPISETRON | 1 | Intravenous (not otherwise specified) | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 89122933 | 8912293 | 12 | C | TROPISETRON | TROPISETRON | 1 | Oral | UNK | 0 | ||||||||||
| 89122933 | 8912293 | 13 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 4 MG, UNK | 0 | 4 | MG | ||||||||
| 89122933 | 8912293 | 14 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 8 MG, UNK | 0 | 8 | MG | ||||||||
| 89122933 | 8912293 | 15 | C | APREPITANT. | APREPITANT | 1 | Oral | 80 AND 125 MG, UNK | 0 | ||||||||||
| 89122933 | 8912293 | 16 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 89122933 | 8912293 | 17 | C | NYSTATIN. | NYSTATIN | 1 | Oral | 1 ML, UNK | 0 | 1 | ML | ||||||||
| 89122933 | 8912293 | 18 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | Oral | 1 DF (TABLET), UNK | 0 | 1 | DF | TABLET | |||||||
| 89122933 | 8912293 | 19 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 0 | TABLET | |||||||||||
| 89122933 | 8912293 | 20 | C | SODIUM BICARBONATE/SODIUM CHLORIDE | 2 | Oral | 10 MG, UNK/10 MG, UNK | 0 | 10 | MG | |||||||||
| 89122933 | 8912293 | 21 | C | SODIUM BICARBONATE/SODIUM CHLORIDE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89122933 | 8912293 | 1 | Colorectal cancer metastatic |
| 89122933 | 8912293 | 2 | Colorectal cancer metastatic |
| 89122933 | 8912293 | 3 | Colorectal cancer metastatic |
| 89122933 | 8912293 | 4 | Colorectal cancer metastatic |
| 89122933 | 8912293 | 5 | Colorectal cancer metastatic |
| 89122933 | 8912293 | 6 | Product used for unknown indication |
| 89122933 | 8912293 | 7 | Product used for unknown indication |
| 89122933 | 8912293 | 8 | Product used for unknown indication |
| 89122933 | 8912293 | 9 | Product used for unknown indication |
| 89122933 | 8912293 | 10 | Product used for unknown indication |
| 89122933 | 8912293 | 11 | Prophylaxis of nausea and vomiting |
| 89122933 | 8912293 | 13 | Prophylaxis of nausea and vomiting |
| 89122933 | 8912293 | 15 | Prophylaxis of nausea and vomiting |
| 89122933 | 8912293 | 16 | Product used for unknown indication |
| 89122933 | 8912293 | 17 | Oral candidiasis |
| 89122933 | 8912293 | 18 | Candida infection |
| 89122933 | 8912293 | 19 | Candida infection |
| 89122933 | 8912293 | 20 | Mucosal inflammation |
| 89122933 | 8912293 | 21 | Mucosal inflammation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89122933 | 8912293 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89122933 | 8912293 | Chest pain | |
| 89122933 | 8912293 | Non-cardiac chest pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89122933 | 8912293 | 1 | 20120717 | 0 | ||
| 89122933 | 8912293 | 2 | 20120717 | 0 | ||
| 89122933 | 8912293 | 3 | 20120717 | 0 | ||
| 89122933 | 8912293 | 4 | 20120717 | 0 | ||
| 89122933 | 8912293 | 5 | 20120717 | 0 | ||
| 89122933 | 8912293 | 11 | 20120717 | 0 | ||
| 89122933 | 8912293 | 12 | 20120717 | 0 | ||
| 89122933 | 8912293 | 13 | 20120718 | 20120719 | 0 | |
| 89122933 | 8912293 | 14 | 20120718 | 20120719 | 0 | |
| 89122933 | 8912293 | 15 | 20120731 | 20120731 | 0 | |
| 89122933 | 8912293 | 16 | 20120801 | 20120802 | 0 | |
| 89122933 | 8912293 | 17 | 20120807 | 0 | ||
| 89122933 | 8912293 | 18 | 20120816 | 0 | ||
| 89122933 | 8912293 | 20 | 20120822 | 0 |